Department of Bioengineering, University of California, Riverside, Riverside, CA 92521, USA.
Department of Neuroscience, University of California, Riverside, Riverside, CA 92521, USA.
Free Radic Biol Med. 2018 May 20;120:356-367. doi: 10.1016/j.freeradbiomed.2018.03.044. Epub 2018 Mar 27.
The high extracellular hydrogen peroxide (HO) concentrations generated during pharmacological ascorbate (P-AscH) therapy has been shown to exhibit a high flux into susceptible cancer cells leading to a decrease in clonogenic survival. It is hypothesized that the intracellular HO concentration for susceptibility is independent of cell type and that the variation observed in dosing is associated with differences in the cell-specific overall steady-state intracellular HO concentration values. The steady-state variation in intracellular HO concentration is coupled to a number of cellular specific transport and reaction factors including catalase activity and membrane permeability. Here a lumped-parameter mathematical modeling approach, assuming a catalase-dominant peroxide removal mechanism, is used to calculate intracellular HO concentration for several cell lines. Experimental measurements of critical parameters pertaining to the model are obtained. The cell lines investigated are normal pancreatic cells, H6c7, the pancreatic cancer cell line, MIA PaCa-2 and the glioblastoma cell lines, LN-229, T98G, and U-87; all which vary in susceptibility. The intracellular HO concentration estimates are correlated with the clonogenic surviving fraction for each cell line, in-vitro. The results showed that, despite the fact that the experimental parameters including catalase concentration and plasma membrane permeability demonstrated significant variability across cell lines, the calculated steady-state intracellular to extracellular HO concentration ratio did not vary significantly across cell lines. Thus, the calculated intracellular HO concentration is not unique in characterizing susceptibility. These results imply that, although intracellular HO concentration plays a key role in cellular susceptibility to P-AscH adjuvant therapy, its overall contribution in a unifying mechanism across cell types is complex.
在药理学抗坏血酸(P-AscH)治疗过程中产生的高细胞外过氧化氢(HO)浓度已被证明具有很高的流入易感性癌细胞的通量,导致集落形成存活能力下降。据推测,细胞内 HO 浓度对易感性是独立于细胞类型的,并且观察到的剂量变化与细胞特异性的总体稳态细胞内 HO 浓度值的差异有关。细胞内 HO 浓度的稳态变化与许多细胞特异性的运输和反应因素有关,包括过氧化氢酶活性和膜通透性。在这里,采用集总参数数学建模方法,假设过氧化氢酶主导的过氧化物去除机制,来计算几种细胞系的细胞内 HO 浓度。获得了与模型相关的关键参数的实验测量值。研究的细胞系是正常胰腺细胞、胰腺癌细胞系 H6c7、MIA PaCa-2 和神经胶质瘤细胞系 LN-229、T98G 和 U-87;所有这些细胞系的易感性都不同。细胞内 HO 浓度估计值与每种细胞系的体外集落形成存活分数相关。结果表明,尽管实验参数包括过氧化氢酶浓度和质膜通透性在细胞系之间表现出显著的可变性,但计算出的稳态细胞内到细胞外 HO 浓度比在细胞系之间没有显著变化。因此,计算出的细胞内 HO 浓度并不能唯一地描述易感性。这些结果表明,尽管细胞内 HO 浓度在细胞对 P-AscH 辅助治疗的敏感性中起着关键作用,但它在跨细胞类型的统一机制中的总体贡献是复杂的。